These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 17061108)

  • 1. MDMA (Ecstasy) use and psychiatric problems.
    Guillot CR; Berman ME
    Psychopharmacology (Berl); 2007 Jan; 189(4):575-6. PubMed ID: 17061108
    [No Abstract]   [Full Text] [Related]  

  • 2. [Psychiatric disorders and consumption of ecstasy drug (MDMA): review of published case reports].
    Bango J; Fadón P; Mata F; Rubio G; Santo-Domingo J
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998; 26(4):260-3. PubMed ID: 9807860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methodological problems with ecstasy and the SCL-90.
    Cole JC; Sumnall HR; Wagstaff GF
    Psychopharmacology (Berl); 2002 Jul; 162(2):215-7; discussion 218-22. PubMed ID: 12110999
    [No Abstract]   [Full Text] [Related]  

  • 4. Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy').
    McCann UD; Slate SO; Ricaurte GA
    Drug Saf; 1996 Aug; 15(2):107-15. PubMed ID: 8884162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Psychiatric and cognitive long-term effects of ecstasy].
    Høiseth G; Løvåsdal Ø; Titze TK; Bramness JG; Bachs L
    Tidsskr Nor Laegeforen; 2006 Feb; 126(5):596-8. PubMed ID: 16505868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quitting ecstasy: an investigation of why people stop taking the drug and their subsequent mental health.
    Verheyden SL; Maidment R; Curran HV
    J Psychopharmacol; 2003 Dec; 17(4):371-8. PubMed ID: 14870948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDMA and the "ecstasy paradigm".
    Cole JC
    J Psychoactive Drugs; 2014; 46(1):44-56. PubMed ID: 24830185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuropsychiatric disorders induced by MDMA ("Ecstasy")].
    Bailly D
    Encephale; 1999; 25(6):595-602. PubMed ID: 10668603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term neuropsychiatric consequences of "ecstasy" (MDMA): a review.
    Montoya AG; Sorrentino R; Lukas SE; Price BH
    Harv Rev Psychiatry; 2002; 10(4):212-20. PubMed ID: 12119307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dark side of ecstasy: neuropsychiatric symptoms after exposure to 3,4-methylenedioxymethamphetamine.
    Karlsen SN; Spigset O; Slørdal L
    Basic Clin Pharmacol Toxicol; 2008 Jan; 102(1):15-24. PubMed ID: 18047478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of ecstasy on the body].
    Saarijärvi S; Lopperi M
    Duodecim; 2003; 119(13):1211-5. PubMed ID: 12908183
    [No Abstract]   [Full Text] [Related]  

  • 12. Neurological and psychopathological sequelae associated with a lifetime intake of 40,000 ecstasy tablets.
    Kouimtsidis C; Schifano F; Sharp T; Ford L; Robinson J; Magee C
    Psychosomatics; 2006; 47(1):86-7. PubMed ID: 16384814
    [No Abstract]   [Full Text] [Related]  

  • 13. MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients.
    Schifano F; Di Furia L; Forza G; Minicuci N; Bricolo R
    Drug Alcohol Depend; 1998 Sep; 52(1):85-90. PubMed ID: 9788011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?
    Gouzoulis-Mayfrank E; Daumann J
    Addiction; 2006 Mar; 101(3):348-61. PubMed ID: 16499508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Club drug use in Germany.
    Soellner R
    Subst Use Misuse; 2005; 40(9-10):1279-93. PubMed ID: 16048817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated impulsivity and impaired decision-making cognition in heavy users of MDMA ("Ecstasy").
    Quednow BB; Kühn KU; Hoppe C; Westheide J; Maier W; Daum I; Wagner M
    Psychopharmacology (Berl); 2007 Jan; 189(4):517-30. PubMed ID: 16425060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consumption and dangers of ecstasy: an amphetamine derivative with a misleading reputation of safety.
    Prescrire Int; 1999 Dec; 8(44):188-9. PubMed ID: 11503823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDMA and serotonin: based on two cases.
    Garcia Cabeza I; Zabala A; Soto-Montenegro ML; Arango C
    Actas Esp Psiquiatr; 2005; 33(5):339-42. PubMed ID: 16155817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumomediastinum following Ecstasy (methylenedioxymetamphetamine, MDMA) ingestion in two people at the same 'rave'.
    Rejali D; Glen P; Odom N
    J Laryngol Otol; 2002 Jan; 116(1):75-6. PubMed ID: 11860664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comment on R. Thomasius, M. Schmolke, D. Kraus: MDMA ("Ecstasy") use--an overview of psychiatric and medical sequelae].
    Gouzoulis-Mayfrank E; Hermle L; Kovar KA; Sass H
    Fortschr Neurol Psychiatr; 1999 Dec; 67(12):574-6. PubMed ID: 10683753
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.